These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 1913660
1. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cote RJ, Jhanwar SC, Novick S, Pellicer A. Cancer Res; 1991 Oct 01; 51(19):5410-6. PubMed ID: 1913660 [Abstract] [Full Text] [Related]
2. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216 [Abstract] [Full Text] [Related]
3. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU. Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438 [Abstract] [Full Text] [Related]
4. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer]. Kashkin KN, Fleĭshman EV, Chumakov PM, Perevoshchikov AG. Genetika; 1998 Aug 01; 34(8):1049-55. PubMed ID: 9777351 [Abstract] [Full Text] [Related]
5. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou ZQ. Cancer Res; 1993 Apr 15; 53(8):1889-94. PubMed ID: 8467510 [Abstract] [Full Text] [Related]
6. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Ruggeri B, Zhang SY, Caamano J, DiRado M, Flynn SD, Klein-Szanto AJ. Oncogene; 1992 Aug 15; 7(8):1503-11. PubMed ID: 1630814 [Abstract] [Full Text] [Related]
7. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma. Adesina AM, Nalbantoglu J, Cavenee WK. Cancer Res; 1994 Nov 01; 54(21):5649-51. PubMed ID: 7923211 [Abstract] [Full Text] [Related]
8. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Murakami Y, Hayashi K, Sekiya T. Cancer Res; 1991 Jul 01; 51(13):3356-61. PubMed ID: 2054775 [Abstract] [Full Text] [Related]
9. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Ruggeri B, Caamano J, Goodrow T, DiRado M, Bianchi A, Trono D, Conti CJ, Klein-Szanto AJ. Cancer Res; 1991 Dec 15; 51(24):6615-21. PubMed ID: 1742735 [Abstract] [Full Text] [Related]
10. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Gerwin BI. Cancer Res; 1992 May 01; 52(9):2610-5. PubMed ID: 1568228 [Abstract] [Full Text] [Related]
11. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Frankel RH, Bayona W, Koslow M, Newcomb EW. Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252 [Abstract] [Full Text] [Related]
12. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152 [Abstract] [Full Text] [Related]
13. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. Fang Y, Elahi A, Denley RC, Rao PH, Brennan MF, Jhanwar SC. Anticancer Res; 2009 Apr 01; 29(4):1255-62. PubMed ID: 19414372 [Abstract] [Full Text] [Related]
15. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation. Albor A, Flessate DM, Soussi T, Notario V. Cancer Res; 1994 Aug 15; 54(16):4502-7. PubMed ID: 8044802 [Abstract] [Full Text] [Related]
16. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Spruck CH, Tsai YC, Huang DP, Yang AS, Rideout WM, Gonzalez-Zulueta M, Choi P, Lo KW, Yu MC, Jones PA. Cancer Res; 1992 Sep 01; 52(17):4787-90. PubMed ID: 1511442 [Abstract] [Full Text] [Related]
17. Occurrence of Ki-ras and p53 mutations in primary colorectal tumors. Shaw P, Tardy S, Benito E, Obrador A, Costa J. Oncogene; 1991 Nov 01; 6(11):2121-8. PubMed ID: 1945416 [Abstract] [Full Text] [Related]
18. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Yaginuma Y, Westphal H. Cancer Res; 1992 Aug 01; 52(15):4196-9. PubMed ID: 1638534 [Abstract] [Full Text] [Related]
20. p53 abnormalities in different subtypes of human sarcomas. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL. Cancer Res; 1993 Feb 01; 53(3):468-71. PubMed ID: 8425179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]